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Phospholipid signalling: Rho is only ARF the story
Michael A. Frohman and Andrew J. Morris
The GTP-binding proteins ARF and Rho control a
number of important cellular processes, such as protein
traffic and cell morphology; there is increasing evidence
that phospholipase D is a key mediator of these
ARF/Rho-regulated events.
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Small GTP-binding proteins act as switches that control
diverse cellular processes. Those in the ADP-ribosylation
factor (ARF) class direct key steps in intracellular protein
traffic, whereas those in the Rho family regulate gene tran-
scription as well as changes in cell motility and morphology
[1,2]. Several groups have now produced evidence that
these regulatory activities of Rho and ARF proteins may be
mediated by phosphatidylcholine (PC)-specific phospholi-
pase D (PLD). PLD generates phosphatidic acid (PA),
which may be an intracellular mediator in its own right and
which can be metabolized to form lipids with proven roles
as both intercellular and intracellular messengers [3].
ARF and Rho regulation of PLD activity
ARFs were initially identified as activators of cholera toxin
ADP-ribosyl transferase activity towards the a subunit of
the heterotrimeric G protein Gs. There are six mammalian
ARFs, which are largely soluble but can bind to mem-
branes in a regulated and GTP-dependent manner. ARFs
play an essential role in intracellular membrane traffic, and
have been implicated in both ER-to-Golgi and intra-Golgi
vesicle transport. Reconstitution studies using mammalian
systems have demonstrated that ARF1 regulates the
assembly of the coat protein complex — the coatomer or
COP — which controls the budding of transport vesicles
from Golgi cisternae [4,5] and presumably also from ER
membranes. Why there are multiple ARFs is poorly
understood, but their existence is presumably important;
ARF6, for example, localizes to the plasma membrane and
regulates receptor-mediated endocytosis [6].
Rho family proteins play dynamic roles in the regulation
of the actin cytoskeleton, thereby controlling various
aspects of cell morphology and motility, depending on the
particular Rho protein involved. Thus, Rac is required for
membrane ruffling and Rho for formation of stress fibers,
and Cdc42 regulates the formation of actin-containing
microspikes called filopodia [7]. The effects of Rho pro-
teins in microinjected cells occur on a time scale that is too
short to involve alterations in gene expression, indicating
that these events must be controlled through other regula-
tory pathways. Thus, Rho proteins, like ARFs, regulate
complex processes in cells and in both cases the precise
steps and mechanisms involved have been unclear.
That PLD is activated following agonist stimulation has
been observed in numerous cell types and with a wide
variety of ligands acting via G-protein-coupled receptors or
receptor tyrosine kinases. While investigating the mecha-
nism of PLD activation, several groups observed PLD
activities in tissues and cell lines that showed guanine-
nucleotide dependence, which was subsequently shown to
be mediated by members of the ARF and Rho families.
Two groups used different approaches to identify ARF as
a GTP-dependent regulator of PLD activity [8,9]. Their
observations were initially made using HL-60 cells as the
source of PLD activity, but PLD enzymes with similar
sensitivity to ARF stimulation (presumably identical or
closely related enzymes) are expressed in other tissues.
The GTP-dependent activation of PLD in neutrophils is
apparently mediated by Rho [10]; furthermore, two Rho-
related G proteins, Rac1 and Cdc42, can also stimulate
several mammalian PLD activities independently of (and
synergistically with) other regulators [11,12].
We have recently reported [13] the cloning and expression
of the human gene encoding PLD1, a G-protein-regulated
PLD. ARF1, and the Rho proteins RhoA, Rac1 and Cdc42,
all activate purified PLD1; the purified enzyme can also be
activated by protein kinase Ca in a novel, kinase-indepen-
dent manner. The G-protein activators are approximately
equipotent, and the three classes of regulators — ARF, Rho
and PKC — activate PLD1 synergistically, suggesting that
they interact with different sites on the enzyme (our unpub-
lished data). Several lines of evidence have suggested the
existence of additional mammalian PLDs (reviewed in
[14]), and our group has recently identified a second mam-
malian PLD, PLD2, which, like PLD1, requires phos-
phatidylinositol 4,5-bisphosphate (PIP2) for activity in vitro
(unpublished data). Mammalian tissues also contain PIP2-
independent PLD activities which are stimulated by fatty
acids such as oleate [15]. It is not known how many mam-
malian PLD enzymes there are, though our molecular
studies [13], which have revealed the existence of a PLD
multigene family, should help clarify this important issue.
What is the function of PLD-generated PA?
Understanding the role of PLD in cellular regulation by
the ARF and Rho proteins will require identification of the
cellular targets and functions of its reaction product, PA.
PA can clearly be metabolized to generate both intracellu-
lar and extracellular messengers — diacylglycerol, arachi-
donic acid and lysophosphatidic acid (reviewed in [14]) —
but it is beginning to appear equally likely that it is also an
intracellular mediator in its own right. For example,
several identified (Raf and certain PKC isoforms) and
unidentified protein kinases have been reported to be acti-
vated by PA in vitro [16], although the physiological impor-
tance of this type of regulation requires further study [3].
As no selective PLD inhibitors have been discovered,
attempts to generate direct evidence supporting in vivo
roles for PLD-generated PA have entailed the direct
administration of PA itself to cells, or the use of primary
alcohols which are used as substrates by PLD for a
transphosphatidylation reaction which generates phos-
phatidylalcohols instead of PA. Exogenously added PA
has been shown to increase, and primary alcohols to
inhibit, actin polymerization leading to stress-fiber forma-
tion in endothelial cells, suggesting a role for PLD as a
mediator of cytoskeletal reorganization [17]. Primary alco-
hols have also been used to demonstrate that secretion by
HL-60 cells and neutrophils is blocked when PA produc-
tion is inhibited, supporting the hypothesis that PLD
plays a role in secretion [18,19].
Caveats should be applied, however, to the interpretation of
both of these experimental approaches. PA is normally pro-
duced intracellularly by PLD, and it is not clear that exoge-
nously applied PA exerts its actions through normal
physiological pathways (as opposed, for example, to stimu-
lating receptors on the cell surface, as lysophosphatidic acid
is known to do). And although phosphatidylalchohols
appear to be metabolically inert, they may nonetheless acti-
vate some PA-dependent processes to an unknown extent.
Moreover, the relatively high concentrations of alcohols
used in these types of experiment may influence these or
other cellular responses through different mechanisms.
The role of PLD1 in ARF and Rho-regulated processes
Given the evidence presented above, it has been tempting
to speculate that PLD activation by ARF and Rho reflects
roles for distinct PLDs in separate pathways — secretion
and signal transduction, respectively. The finding that
PLD1 is regulated by both ARF and Rho, however, sup-
ports a blurring of this distinction and suggests that the
two processes may be more integrated than previously rec-
ognized. Several lines of evidence support this idea. For
example, most ARF is found in the cytosol in HL-60 cells
[20]; immediately after stimulation with a ligand agonist
(fMet-Leu-Phe), however, much of the cytosolic ARF
becomes membrane-bound in the Golgi apparatus. This
suggests that ARF should be viewed as a participant in the
signal transduction process, and that secretion in this
instance is a regulated consequence of specific agonist-
stimulated events.
Rothman and colleagues [4] reported that coatomer
assembly can be reconstituted in washed Golgi membrane
preparations with the addition of just ARF and coatomer.
It is likely, however, that PLD was present in these exper-
iments, as it is tightly associated with membranes and
present in significant amounts in the Golgi apparatus [21].
Sternweis, Roth and colleagues [21,22] have begun to
establish that ARF-activated PLD does indeed have an
important role in intracellular protein traffic. They have
found that ARF-activated PLD is enriched in Golgi mem-
branes, and provided several lines of evidence that PA
formed through ARF stimulation of PLD plays an impor-
tant role in coatomer binding. This suggests the model
shown in Figure 1, in which activation of Golgi-mem-
brane-associated PLD1 by ARF leads to recruitment of
the cytosolic coatomer complex, and consequent alter-
ations in membrane structure leading to vesicle budding.
The synergistic effect of Rho on ARF stimulation of PLD1
activity in vitro suggests that this enzyme may act as an
integrative regulator of both constitutive secretion, pre-
sumably under the control of ARF, and receptor-regulated
946 Current Biology 1996, Vol 6 No 8
Figure 1
PLD1- and ARF-dependent formation of coated vesicles. PLD1
participates in the ‘priming’ step of coated vesicle formation by
catalyzing hydrolysis of PC to produce PA, which, perhaps acting in
concert with ARF, results in coatomer binding to the membrane
surface (possibly mediated by a putative ‘coatomer receptor’).
Coatomer assembly then results in deformation of the membrane
surface (vesiculation), leading to bud formation and release of a coated
vesicle (budding). We suggest that activation of PLD1 by ARF and
Rho (and PKC) links this process of coated-vesicle formation to
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increases in secretion in response to activation by Rho and
possibly PKC. In support of this is evidence that Rho, Rac
and Cdc42 play a role in enhancing regulated secretion of
interleukin 2 by T cells, and in ensuring that this secretion
takes place in a polarized manner (towards the immune
cell intended to be the beneficiary of the secreted inter-
leukin) [23]. ARF-dependent secretion from permeabi-
lized HL-60 cells, and ARF-mediated PLD activation, are
greatly potentiated by pretreating the cells with phorbol
esters, supporting the idea that a synergistic collaboration
by other PLD activators, in this instance PKCa, leads to
increased secretion [24]. Based on the synergistic activa-
tion described above, PLD1 is a good candidate to be the
mediator of this process.
PLD activation by ARF and by the Rho proteins may,
therefore, reflect two different aspects of the same physio-
logical response: cytoskeletal reorganization leading to cel-
lular polarization and then temporally and spatially
regulated secretion. We suggest that PLD1 is uniquely
positioned to receive and integrate different kinds of
extracellular and intracellular signals initiated by activa-
tion of Rho and ARF, and to transduce them to generate
lipid-derived molecules that, in turn, mediate cell-specific
responses involving secretion, and perhaps related
changes in cell morphology and motility.
Future questions
Several important pieces of this puzzle are still missing.
How are the ARF and Rho proteins activated (and deacti-
vated) and do they couple cell-surface receptors to PLD
activation? Presumably these processes involve a number
of accessory proteins, but the mechanisms involved are
not known. What is the function of PLD-generated PA?
Does this lipid exert its effects by changing the structure
or surface charge of membranes — suggested to be the
mechanism by which ARF-activated PLD regulates
coatomer binding and vesicle budding — or does it act
through specific protein targets? In what cellular compart-
ments does PLD1 operate? Given the complex regulation
of PLD1 observed in vitro, perhaps the enzyme is
expressed in different compartments where different
modes of regulation predominate. The suggestion that
ARF-dependent PLD1 activation in the Golgi apparatus
generates PA for coated-vesicle formation does not pre-
clude the possibility that PKC and/or Rho-dependent acti-
vation of PLD1 at different sites could have other
consequences. What is the role of the other PLD isoforms,
such as PLD2? With the availability of PLD-encoding
cDNAs, recombinant proteins and isoenzyme-selective
antibodies, answers to many of these questions should be
forthcoming.
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